These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection. Shao X, Ma J, Jia S, Yang L, Wang W, Jin Z. Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338 [Abstract] [Full Text] [Related]
13. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, Zhang SY, Li BS, Wang HF, Wu H, Lau GK, Fu YX, Wang FS. Gastroenterology; 2008 Jun 13; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515 [Abstract] [Full Text] [Related]
14. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma. Liu F, Zeng G, Zhou S, He X, Sun N, Zhu X, Hu A. Bull Cancer; 2018 May 13; 105(5):493-501. PubMed ID: 29576222 [Abstract] [Full Text] [Related]
17. Role of Tim-3 in hepatitis B virus infection: An overview. Liu Y, Gao LF, Liang XH, Ma CH. World J Gastroenterol; 2016 Feb 21; 22(7):2294-303. PubMed ID: 26900291 [Abstract] [Full Text] [Related]